pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,379 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: recall×clear all
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06138275: Elranatamab in R/R Multiple Myeloma

    Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07487857: Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy

    Sponsor: University of Castilla-La Mancha. Phase: NA. Conditions: Cerebral Palsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633457: Comparison Between Outcomes of Closure of Idiopathic Macular Hole Using Autologus Tenon Capsule Graft and Internal Limiting Membrane Flap Techniques (Pilot Study)

    Sponsor: Ain Shams University. Phase: NA. Conditions: Macular Hole Surgery, ILM Peeling, Tenon Capsule, ILM Flap, Macular Hole

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05753501: Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372157: Neuromuscular Balance Exercise Effects in Overweight and Obese Individuals

    Sponsor: Marmara University. Phase: NA. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06245057: Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Morbidity;Perinatal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07084857: Association Between Isokinetic Lower Extremity Muscle Strength and Bone Mineral Density in Elderly Women With and Without Osteoporosis

    Sponsor: Cairo University. Phase: . Conditions: Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497101: Effectiveness Trial of Temperament Based Therapy With Support (TBT-S)

    Sponsor: Oslo University Hospital. Phase: NA. Conditions: Anorexia Nervosa

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07556601: Ultra-rapid Blastocyst Vitrification: Pilot Randomized Study

    Sponsor: Fundacion Dexeus. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04799301: Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake

    Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: PHASE1. Conditions: Diet Therapy, Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07541001: PRL3-Zumab in Patients With Advanced Solid Tumors

    Sponsor: Intra-IMMUSG Pte Ltd. Phase: PHASE2. Conditions: Advanced Malignant Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07606001: Yellow Potatoes and Carotenoids

    Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04431479: Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

    Sponsor: Fred Hutchinson Cancer Center. Phase: . Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06871579: Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Helicobacter Pylori

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530588: Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis

    Sponsor: University Hospital of North Norway. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04838288: Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

    Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Renal Transplant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07474688: Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure

    Sponsor: China-Japan Friendship Hospital. Phase: . Conditions: Uterine Fibroids (Leiomyoma)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282588: Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

    Sponsor: Cancer Research Antwerp. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01969227: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05996627: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

    Sponsor: Fred Hutchinson Cancer Center. Phase: PHASE2. Conditions: Chronic Graft Versus Host Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545461: Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

    Sponsor: Donald Wesson. Phase: NA. Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06037161: Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums

    Sponsor: Case Western Reserve University. Phase: NA. Conditions: Recession, Gingival

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506486: Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study)

    Sponsor: Universitas Padjadjaran. Phase: NA. Conditions: Stroke (Subacute)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07336186: The Effect of Virtual Reality-Based Relaxation on Breast Milk Volume and Breastfeeding Self-Efficacy in Mothers of Preterm Infants

    Sponsor: Kocaeli University. Phase: NA. Conditions: Lactation, Breastfeeding, Premature Birth, Maternal Stress, Self-Efficacy

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05089786: Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001)

    Sponsor: InSightec. Phase: NA. Conditions: Essential Tremor, Neurology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07634770: Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

    Sponsor: Sam Chun Dang Pharm. Co. Ltd.. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07610473: A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

    Sponsor: Draig Therapeutics Ltd. Phase: PHASE2. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07619469: Motion Sickness Severity and Sensorimotor Performance

    Sponsor: Istinye University. Phase: . Conditions: Motion Sickness, Somatosensory Disorders, Dizziness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054269: Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

    Sponsor: Centers for Disease Control and Prevention. Phase: PHASE3. Conditions: Influenza

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07121283: Artificial Intelligence Assisted Bone Age Assessment

    Sponsor: Cheng-Hsin General Hospital. Phase: NA. Conditions: Bone Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02530983: Mayo Clinic Upper Digestive Disease Survey

    Sponsor: Mayo Clinic. Phase: . Conditions: Esophageal Neoplasms, Cancer of Esophagus, Cancer of the Esophagus, Esophageal Cancer, Esophagus Cancer, Neoplasm, Esophageal, Esophagectomy, Abnormalities, Digestive System, Digestive System Abnormalities

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04002141: Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Endometriosis, Ovarian Hyperstimulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06334354: A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06105541: Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile Ehlers-Danlos Syndrome, Hypermobile Spectrum Disorder, Ehlers-Danlos Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06940141: Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

    Sponsor: Connect Biopharm LLC. Phase: PHASE2. Conditions: Asthma Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07435441: Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

    Sponsor: Istanbul Arel University. Phase: . Conditions: Post-stroke, Dysphagia, Videofluoroscopy, Scale Reliability Validity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997094: Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

    Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Human Papillomavirus-Negative Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma, Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma, Resectable Head and Neck Squamous-cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06665594: Effect of TXA on Reducing Bruising After Filler Injection

    Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Facial Filler Injections, Hyaluronic Acid, Tranexamic Acid

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05687266: Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: NSCLC

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05558566: Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

    Sponsor: Yale University. Phase: NA. Conditions: Tourette Syndrome in Adolescence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01625351: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE1. Conditions: Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor, Hepatic Tumor, Lymphoma, Wilms Tumor, Rhabdoid Tumor, Clear Cell Carcinoma, Renal Cell Carcinoma, Melanoma, Neuroblastoma, Rhabdomyosarcoma, Non-rhabdomyosarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07570329: Human Milk Oligosaccharides, Gut Bifidobacterium, Vitamin D, and Infant Immunity

    Sponsor: Hasanuddin University. Phase: . Conditions: Healhty

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05203731: Level of Physical Activity and Fear Learning

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06156202: Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve Functioning of Persons Suffering From Post-COVID-19 Syndrome: A Randomized Controlled Trial

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 Infection, Long COVID, Long Covid19, Dyspnea, Orthostasis, Cognitive Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04857502: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Prostate Carcinoma, Recurrent Prostate Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04850053: Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

    Sponsor: Capital Medical University. Phase: . Conditions: Alzheimer's Disease

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03799445: Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Basaloid Carcinoma, Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Posterior Tongue Squamous Cell Carcinoma, Soft Palate Squamous Cell Carcinoma, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Tonsillar Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06367972: A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: OligoProgressive Metastatic Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06907472: Diabetes Management for Primary Healthcare Centers.

    Sponsor: University of Abuja. Phase: NA. Conditions: Type 2 Diabetes Mellitus (T2DM)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04310995: Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

    Sponsor: Ruijin Hospital. Phase: PHASE4. Conditions: Coronary Artery Bypass Graft, Radial Artery Grafts, Antispastic Therapy, Pilot Study

    full page →ctgov ↗
    ← prev
    page 71 of 108
    next →